Homecare Acquisition in France


Air Liquide, number one in the European homecare market, has just completed the
100% acquisition of DinnoSanté, a company that specializes in medical-technical
services for diabetes.

DinnoSanté is a French company with 90 employees which specializes in the
equipment and home monitoring of patients with diabetes. It supplies nearly
2,300 chronic diabetes patients with equipment designed to facilitate their lives,
including insulin pumps and glucose meters, and supporting them with personalized
training and regular follow-up.

Diabetes is a major chronic illness whose development is in large part linked to
changes in lifestyle as well as an aging population. In France, more than 2.5 million
people are being treated for diabetes, a figure that is constantly rising. Advances in
treatment technologies and the growing use of insulin pumps help to improve the
quality of life of the patients by giving them greater mobility as well as greater flexibility
of use.

This acquisition reinforces Air Liquide's offer in taking charge of pathologies that are
treatable at home: sleep apnea (frequent in patients with diabetes), chronic respiratory
disease, etc.

Pascal Vinet, Vice-President, Healthcare World Business Line and Healthcare
Operations, Air Liquide Group, commented: "This new Healthcare acquisition
illustrates our development strategy which seeks to strengthen our global
range of services related to homecare treatments. Health is a solid and
promising growth driver for the Air Liquide Group."

All Topics